corporate funder

Ipsen Biopharmaceuticals, Inc. (US)

www.ipsen.com (opens in a new tab)1 openCatalog updated

Open programs1

  1. RFP for Case Reports/Case Series on Odevixibat

    Ipsen is issuing an RFP for case reports or case series on real-world use of odevixibat for pruritus in Progressive Familial Intrahepatic Cholestasis (PFIC) and cholestatic pruritus of Alagille syndrome, with potential support including financial reimbursement and/or study drug supply subject to a written agreement.

    Research ProjectHealth

    Deadline
    Amount
    Not listed

Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.

Same type

More corporate funders

See FundFit match these programs to your researchers.

Request a demo

Or browse every funder in the directory →